Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00008
http://purl.obolibrary.org/obo/dinto_DB00008
|
|---|---|
| Preferred Name | peginterferon alfa-2a |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | peginterferon alfa-2a
|
|---|---|
| label | peginterferon alfa-2a
|
| ATCCode | L03AB11
|
| Definition | Human interferon 2a, is a covalent conjugate of recombinant alfa-2a interferon with a single branched bis-monomethoxy polyethylene glycol (PEG) chain. The PEG moiety is linked at a single site to the interferon alfa moiety via a stable amide bond to lysine. Peginterferon alfa-2a has an approximate molecular weight of 60,000 daltons. Interferon alfa-2a is produced using recombinant DNA technology in which a cloned human leukocyte interferon gene is inserted into and expressed in Escherichia coli. The resultant protein is 165 amino acids. The PEG strand protects the molecule in vivo from proteolytic breakdown, substantially increases its in vivo half-life, and reduces immunogenicity by wrapping around and physically hindering access to the protein portion of the molecule.
|
| has pharmacological target | |
| activates | |
| type | |
| AHFScode | 08:18.20
|
| xref |
Drugs Product Database (DPD):2248077
RxList:http://www.rxlist.com/cgi/generic3/pegasys.htm
UniProtKB:P01563
PharmGKB:PA164749390
Wikipedia:http://en.wikipedia.org/wiki/Peginterferon_alfa-2a
Drugs.com:http://www.drugs.com/cdi/peginterferon-alfa-2a.html
GenBank:J00207
See more
See less
|
| CASRN | 198153-51-4
|
| prefixIRI | obo2:dinto_DB00008
|
| may interact with | |
| DBBrand |
pegasys (hoffman-la roche inc)
pegasys
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |